The learning curve for sentinel node biopsy in breast cancer: practical considerations

Area of Science:

• Oncology
• Surgical Oncology
• Breast Cancer Management

Background:

• Sentinel lymph node biopsy (SNB) is increasingly used for breast cancer staging.
• Surgeon inexperience during the learning curve of SNB may impact its accuracy and patient outcomes.
• Full axillary lymph node dissection (ALND) is the traditional staging method but carries higher morbidity.

Purpose of the Study:

• To evaluate the implications of SNB versus ALND during the initial learning phase for surgeons.
• To assess the impact of surgeon inexperience on breast cancer understaging and costs associated with SNB.
• To determine the threshold for accurate SNB performance to ensure cost-effectiveness and oncologic safety.

Main Methods:

• A decision analysis model simulating 10,000 women per arm (SNB vs. ALND) during the surgeon's learning curve (60-80 procedures).
• Utilized published data on learning curves for SNB to estimate performance metrics.
• Compared rates of inaccurate staging, survival outcomes, and costs between SNB and ALND.

Main Results:

• During the learning phase, SNB had a 38% failure rate in sentinel node identification and 12% understaging rate, compared to 10% and 0% in later cases, respectively.
• Understaging associated with early SNB use led to a 1%-2% decrease in survival and increased axillary recurrence risk.
• SNB became cost-effective only when sentinel node detection rates exceeded 80% and SNB costs were less than 50% of ALND costs.

Conclusions:

• Full ALND should be performed by all surgeons during the learning phase of SNB to ensure accurate breast cancer staging.
• Omitting ALND for women with negative sentinel nodes should only occur after demonstrating high SNB accuracy (sensitivity >90%).
• Prioritizing surgeon proficiency in SNB is crucial to avoid understaging and ensure optimal patient outcomes in breast cancer care.